Micro-CT Imaging of RGD-Conjugated Gold Nanorods Targeting Tumor In Vivo

Journal of Nanomaterials

Volumn 2016, Issue , 2016, Pages

  Qu, Xiaochao ^a   Li, Xiaoxiao ^a   Liang, Jingning ^a   Wang, Yanran ^a   Liu, Muhan ^a   Liang, Jimin ^a  

^a XIDIAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING ENERGY; BIOCOMPATIBILITY; CELLS; CYTOLOGY; GOLD; NANORODS; PEPTIDES; PLASMONS; TUMORS;

BINDING AFFINITIES; CONTRAST AGENT; DARK FIELD IMAGING; GOLD NANORODS (AUNRS); IMAGING CAPABILITIES; STABILITY MEASUREMENTS; TOXIC SIDE EFFECTS; TUMOR TARGETING;

COMPUTERIZED TOMOGRAPHY;

EID: 84982153288     PISSN: 16874110     EISSN: 16874129     Source Type: Journal    
DOI: 10.1155/2016/8368154     Document Type: Article

References (49)

1. P. Ray, "Multimodality molecular imaging of disease progression in living subjects, " Journal of Biosciences, vol. 36, no. 3, pp. 499-504, 2011.
2. P. Huang, L. Bao, C. Zhang et al., "Folic acid-conjugated silicamodified gold nanorods for X-ray/CT imaging-guided dualmode radiation and photo-thermal therapy, " Biomaterials, vol. 32, no. 36, pp. 9796-9809, 2011.
3. R. Popovtzer, A. Agrawal, N. A. Kotov et al., "Targeted gold nanoparticles enable molecular CT imaging of cancer, " Nano Letters, vol. 8, no. 12, pp. 4593-4596, 2008.
4. L. Li, L. Zhang, T. Wang et al., "Facile and scalable synthesis of novel spherical Au nanocluster assemblies@polyacrylic acid/calciumphosphate nanoparticles for dual-modal imagingguided cancer chemotherapy, " Small, vol. 11, no. 26, pp. 3162-3173, 2015.
5. X. Qu, Y. Li, L. Li, Y. Wang, J. Liang, and J. Liang, "Fluorescent gold nanoclusters: synthesis and recent biological application, " Journal of Nanomaterials, vol. 2015, Article ID784097, 23 pages, 2015.
6. A. Antonelli, C. Sfara, E. Manuali, I. J. Bruce, and M. Magnani, "Encapsulation of superparamagnetic nanoparticles into red blood cells as new carriers of MRI contrast agents, " Nanomedicine, vol. 6, no. 2, pp. 211-223, 2011.
7. X. Cui, S. Belo, D. Krüger et al., "Aluminium hydroxide stabilised MnFe2O4 and Fe3O4 nanoparticles as dual-modality contrasts agent for MRI and PET imaging, " Biomaterials, vol. 35, no. 22, pp. 5840-5846, 2014.
8. K. Morishige, D. F. Kacher, P. Libby et al., "High-resolutionmagnetic resonance imaging enhanced with superparamagnetic nanoparticlesmeasuresmacrophage burden in atherosclerosis, " Circulation, vol. 122, no. 17, pp. 1707-1715, 2010.
9. C. R. Anderson, X. Hu, H. Zhang et al., "Ultrasound molecular imaging of tumor angiogenesis with an integrin targeted microbubble contrast agent, " Investigative Radiology, vol. 46, no. 4, pp. 215-224, 2011.
10. J. K. Willmann, R. H. Kimura, N. Deshpande, A. M. Lutz, J. R. Cochran, and S. S. Gambhir, "Targeted contrast-enhanced ultrasound imaging of tumor angiogenesis with contrast microbubbles conjugated to integrin-binding knottin peptides, " Journal of Nuclear Medicine, vol. 51, no. 3, pp. 433-440, 2010.
11. S. M. Janib, A. S. Moses, and J. A. MacKay, "Imaging and drug delivery using theranostic nanoparticles, " Advanced Drug Delivery Reviews, vol. 62, no. 11, pp. 1052-1063, 2010.
12. T. Reuveni, M. Motiei, Z. Romman, A. Popovtzer, and R. Popovtzer, "Targeted gold nanoparticles enable molecular CT imaging of cancer: an in vivo study, " International Journal of Nanomedicine, vol. 6, pp. 2859-2864, 2011.
13. N. Lee, S. H. Choi, and T. Hyeon, "Nano-sized CT contrast agents, " Advanced Materials, vol. 25, no. 19, pp. 2641-2660, 2013.
14. T. Luo, P. Huang, G. Gao et al., "Mesoporous silica-coated gold nanorods with embedded indocyanine green for dual mode Xray CT and NIR fluorescence imaging, " Optics Express, vol. 19, no. 18, pp. 17030-17039, 2011.
15. J. Zhang, C. Li, X. Zhang et al., "In vivo tumor-targeted dual-modal fluorescence/CT imaging using a nanoprobe coloaded with an aggregation-induced emission dye and gold nanoparticles, " Biomaterials, vol. 42, pp. 103-111, 2015.
16. A. Jakhmola, N. Anton, and T. F. Vandamme, "Inorganic nanoparticles based contrast agents for X-ray computed tomography, " Advanced HealthcareMaterials, vol. 1, no. 4, pp. 413-431, 2012.
17. C. Haller and I. Hizoh, "The cytotoxicity of iodinated radiocontrast agents on renal cells in vitro, " Investigative Radiology, vol. 39, no. 3, pp. 149-154, 2004.
18. I. Hizoh and C. Haller, "Radiocontrast-induced renal tubular cell apoptosis: hypertonic versus oxidative stress, " Investigative Radiology, vol. 37, no. 8, pp. 428-434, 2002.
19. M. Shilo, T. Reuveni, M. Motiei, and R. Popovtzer, "Nanoparticles as computed tomography contrast agents: current status and future perspectives, " Nanomedicine, vol. 7, no. 2, pp. 257-269, 2012.
20. http://physics. nist. gov/PhysRefData/XrayMassCoef.
21. A. Ding, Y. Chen, C. C. Wang, P. Li, and D. Shieh, "HER-2 antibody conjugated gold nano rod for in vivo photothermal therapy, " in Proceedings of the 8th IEEE Conference on Nanotechnology (NANO '08), pp. 882-885, IEEE, 2008.
22. C. J. Murphy, L. B. Thompson, A. M. Alkilany et al., "The many faces of gold nanorods, "The Journal of Physical Chemistry Letters, vol. 1, no. 19, pp. 2867-2875, 2010.
23. P. Yan, N. Zhao, H. Hu, X. Lin, F. Liu, and F.-J. Xu, "A facile strategy to functionalize gold nanorods with polycation brushes for biomedical applications, " Acta Biomaterialia, vol. 10, no. 8, pp. 3786-3794, 2014.
24. D. P. K. Lankveld, R. G. Rayavarapu, P. Krystek et al., "Blood clearance and tissue distribution of PEGylated and non-PEGylated gold nanorods after intravenous administration in rats, " Nanomedicine, vol. 6, no. 2, pp. 339-349, 2011.
25. H. Liao and J. H. Hafner, "Gold nanorod bioconjugates, " Chemistry of Materials, vol. 17, no. 18, pp. 4636-4641, 2005.
26. S. Liu, "Radiolabeled cyclic RGD peptides as integrin 3-targeted radiotracers: maximizing binding affinity via bivalency, " Bioconjugate Chemistry, vol. 20, no. 12, pp. 2199-2213, 2009.
27. Z. Liu, B. Jia, J. Shi et al., "Tumor uptake of the RGD dimeric probe Tc99m-G3-2P4-RGD2 is correlated with integrin V 3 expressed on both tumor cells and neovasculature, " Bioconjugate Chemistry, vol. 21, no. 3, pp. 548-555, 2010.
28. Z. Liu, J. Shi, B. Jia et al., "Two 90Y-labeled multimeric RGD peptides RGD4 and 3PRGD2 for integrin targeted radionuclide therapy, " Molecular Pharmaceutics, vol. 8, no. 2, pp. 591-599, 2011.
29. B. Nikoobakht and M. A. El-Sayed, "Preparation and growth mechanism of gold nanorods (NRs) using seed-mediated growthmethod, " Chemistry ofMaterials, vol. 15, no. 10, pp. 1957-1962, 2003.
30. J. Choi, J. Yang, J. Park et al., "Specific near-IR absorption imaging of glioblastomas using integrin-targeting gold nanorods, " Advanced Functional Materials, vol. 21, no. 6, pp. 1082-1088, 2011.
31. A. J. Gormley, A. Malugin, A. Ray, R. Robinson, and H. Ghandehari, "Biological evaluation of RGDfK-gold nanorod conjugates for prostate cancer treatment, " Journal of Drug Targeting, vol. 19, no. 10, pp. 915-924, 2011.
32. J. F. Hainfeld, D. N. Slatkin, and H. M. Smilowitz, "The use of gold nanoparticles to enhance radiotherapy in mice, " Physics in Medicine and Biology, vol. 49, no. 18, pp. N309-N315, 2004.
33. H.-X. Xia, X.-Q. Yang, J.-T. Song et al., "Folic acid-conjugated silica-coated gold nanorods and quantum dots for dualmodality CT and fluorescence imaging and photothermal therapy, " Journal of Materials Chemistry B, vol. 2, no. 14, pp. 1945-1953, 2014.
34. J. F. Hainfeld, D. N. Slatkin, T. M. Focella, and H. M. Smilowitz, "Gold nanoparticles: a new X-ray contrast agent, " The British Journal of Radiology, vol. 79, no. 939, pp. 248-253, 2006.
35. T. Niidome, M. Yamagata, Y. Okamoto et al., "PEG-modified gold nanorods with a stealth character for in vivo applications, " Journal of Controlled Release, vol. 114, no. 3, pp. 343-347, 2006.
36. D. Kim, S. Park, J. H. Lee, Y. Y. Jeong, andS. Jon, "Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo X-ray computed tomography imaging, " Journal of the American Chemical Society, vol. 129, no. 24, pp. 7661-7665, 2007.
37. Q.-Y. Cai, S. H. Kim, K. S. Choi et al., "Colloidal gold nanoparticles as a blood-pool contrast agent for X-ray computed tomography in mice, " Investigative Radiology, vol. 42, no. 12, pp. 797-806, 2007.
38. P. K. Jain, K. S. Lee, I. H. El-Sayed, and M. A. El-Sayed, "Calculated absorption and scattering properties of gold nanoparticles of different size, shape, and composition: applications in biological imaging and biomedicine, " The Journal of Physical Chemistry B, vol. 110, no. 14, pp. 7238-7248, 2006.
39. A. Gole and C. J. Murphy, "Polyelectrolyte-coated gold nanorods: synthesis, characterization and immobilization, " Chemistry of Materials, vol. 17, no. 6, pp. 1325-1330, 2005.
40. Z. Sun, W. Ni, Z. Yang, X. Kou, L. Li, and J. Wang, "pH-controlled reversible assembly and disassembly of gold nanorods, " Small, vol. 4, no. 9, pp. 1287-1292, 2008.
41. Y. Niidome, K. Honda, K. Higashimoto et al., "Surface modification of gold nanorodswith synthetic cationic lipids, " Chemical Communications, no. 36, pp. 3777-3779, 2007.
42. C. L. Gladson, "Expression of integrin ]3 in small blood vessels of glioblastoma tumors, " Journal of Neuropathology & Experimental Neurology, vol. 55, no. 11, pp. 1143-1149, 1996.
43. L. Bello, M. Francolini, P. Marthyn et al., "v3 and v5 integrin expression in glioma periphery, " Neurosurgery, vol. 49, no. 2, pp. 380-390, 2001.
44. M. Bartneck, H. A. Keul, M. Wambach et al., "Effects of nanoparticle surface-coupled peptides, functional endgroups, and charge on intracellular distribution and functionality of human primary reticuloendothelial cells, " Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 8, no. 8, pp. 1282-1292, 2012.
45. Z. Li, P. Huang, X. Zhang et al., "RGD-conjugated dendrimermodified gold nanorods for in vivo tumor targeting and photothermal therapy, " Molecular Pharmaceutics, vol. 7, no. 1, pp. 94-104, 2010.
46. R. Haubner, W. A. Weber, A. J. Beer et al., "Noninvasive visualization of the activated v3 integrin in cancer patients by positron emission tomography and [18F]Galacto-RGD, " PLoS Medicine, vol. 2, no. 3, article e70, 2005.
47. J. F. Hainfeld, M. J. O'Connor, F. A. Dilmanian, D. N. Slatkin, D. J. Adams, and H. M. Smilowitz, "Micro-CT enables microlocalisation and quantification of Her2-targeted gold nanoparticles within tumour regions, " British Journal of Radiology, vol. 84, no. 1002, pp. 526-533, 2011.
48. Y. Dou, Y. Guo, X. Li et al., "Size-tuning ionization to optimize gold nanoparticles for simultaneous enhanced CT imaging and radiotherapy, " ACS Nano, vol. 10, no. 2, pp. 2536-2548, 2016.
49. R. S. H. Yang, L. W. Chang, J.-P. Wu et al., "Persistent tissue kinetics and redistribution of nanoparticles, quantum dot 705, in mice: ICP-MS quantitative assessment, " Environmental Health Perspectives, vol. 115, no. 9, pp. 1339-1343, 2007.